Join the Ozempic group to help and get support from people like you.
Ozempic News
Only One-Quarter of Patients Still Taking Semaglutide for Weight Loss Two Years Later
FRIDAY, July 12, 2024 – Three of four patients stop taking semaglutide (Ozempic or Wegovy) two years after being prescribed the glucagon-like peptide-1 receptor agonist (GLP-1 RA) for weight loss,...
GLP-1 RAs May Reduce Risk for Some Obesity-Linked Cancers Versus Insulin in T2D
THURSDAY, July 11, 2024 – For patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for 10 of 13 obesity-associated cancers...
Only 1 in 4 Still Taking Ozempic, Wegovy for Weight Loss Two Years Later
THURSDAY, July 11, 2024 – Three of four patients stop taking Ozempic or Wegovy two years after being prescribed the blockbuster drugs for weight loss, a new analysis shows. Conducted by Prime...
Significantly More Weight Loss Seen With Tirzepatide Versus Semaglutide
MONDAY, July 8, 2024 – Tirzepatide is associated with significantly greater weight loss than semaglutide for adults with overweight or obesity, according to a study published online July 8 in JAMA...
Semaglutide Cuts MACE in People With Overweight, Obesity, Regardless of HbA1c
TUESDAY, July 9, 2024 – Semaglutide reduces cardiovascular events, regardless of baseline glycated hemoglobin (HbA1c), among people with overweight or obesity and established atherosclerotic...
Wegovy, Ozempic Lower Risk of Many Obesity-Related Cancers
MONDAY, July 8, 2024 – In yet another finding that touts the health benefits of wildly popular weight-loss medications like Wegovy and Ozempic, scientists report that taking the drugs may help...
Mounjaro Bests Ozempic for Weight Loss
MONDAY, July 8, 2024 – Mounjaro outperforms Ozempic in helping people lose weight, a new study shows. People taking tirzepatide (Mounjaro, Zepbound) dropped significantly more pounds than those...
Semaglutide Linked to Nonarteritic Anterior Ischemic Optic Neuropathy
WEDNESDAY, July 3, 2024 – Semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes (T2D) and those with overweight/obesity,...
GLP-1 Drugs Ozempic, Wegovy Linked to Rare Blinding Condition
WEDNESDAY, July 3, 2024 – Trendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study warns. People with diabetes prescribed semaglutide...
Another Study Suggests GLP-1 Meds Could Ease Alcoholism
TUESDAY, July 2, 2024 – Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says. People taking semaglutide had 50% to 56% decreased odds for either...
Another Study Suggests GLP-1 Meds Could Ease Alcoholism
TUESDAY, July 2, 2024 – Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says. People taking semaglutide had 50% to 56% decreased odds for either...
American Diabetes Association, June 21-24
The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world, including clinicians,...
ADA: Semaglutide Similarly Effective in Men, Women With Obesity-Linked Heart Failure
WEDNESDAY, June 26, 2024 – For patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight to a greater extent in women but yields similar...
Semaglutide Cuts Incidence, Recurrence of Alcohol Use Disorder
TUESDAY, June 25, 2024 – Semaglutide may cut incidence and recurrence of alcohol use disorder (AUD) in patients with obesity, according to a study published online May 28 in Nature Communications. ...
WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs
FRIDAY, JUNE 21, 2024 – Both the World Health Organization and Eli Lilly Co. warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Cardiovascular Risk Reduction, Diabetes, Type 2